MDMA News
FOR IMMEDIATE RELEASE First MDMA-Assisted Therapy for PTSD Approved in Manitoba A major step forward for access to mental health treatment in the province. WINNIPEG, MB, February 18, 2026 — In a landmark development for mental health care in the Prairies, the Enhanced Therapy Institute (ETI) has secured Manitoba’s first … Read more
TheraPsil Expands Global Training Footprint: New Psilocybin Program for NZ/AU, & Spanish-Language MDMA Training TheraPsil is expanding its internationally recognized training programs with two upcoming cohorts designed specifically for healthcare professionals in New Zealand & Australia and Spanish-speaking communities around the world. While originally planned for Fall 2025, both programs are currently being rescheduled, … Read more
New Partnership: First Session x TheraPsil We’re excited to announce a new partnership between TheraPsil and First Session, a therapist-first platform designed to help you grow your private practice and connect with the right clients — especially if you offer psychedelic-assisted therapy. As part of this partnership: TheraPsil members receive 40% off the cost of … Read more
A new report from Health Canada’s Canadian Substance Use Survey (CSUS) 2023 shows that psychedelic use has surged across Canada, especially among young adults. *5.9% of Canadians (1.93 million people) reported using psychedelics in the past year-a 195% increase from 2019. *MDMA use jumped 80%, from 353,000 people in 2019 to 589,000 in 2023. *22.9% … Read more
TheraPsil community members, including Dr. Ingrid Pacey and patient Brad Gagnon, chatted yesterday morning on CBC’s The Current with Matt Galloway about the transformative potential of MDMA-assisted psychotherapy. Hear Brad, a former police officer, describe his own journey of healing and learn how the perception of MDMA solely as a party drug is beginning to … Read more
Psychiatrist Cheryl Willsie spent nearly a week in Hamilton learning how to walk a patient through an experience on psychedelic drugs. She and two other healthcare professionals learned how to prepare a patient for a therapy session where they take psilocybin – the psychedelic compound in so-called magic mushrooms. Willsie also learned how to support … Read more
A bipartisan group of congressional lawmakers filed a bill this week to clarify that federal “Right to Try” (RTT) laws give seriously ill patients access to Schedule I drugs, including marijuana and psychedelics like psilocybin and MDMA. While the bipartisan measure would make a technical amendment to the text of existing law, the primary purpose … Read more
From a global perspective, Canada has always been on the leading edge of health care policy. With the introduction of medical assistance in dying laws in 2016 and the legalization of cannabis in 2018, we continue to make progress. But there’s one area in which our federal government’s delay has recently come into sharp focus: … Read more
IN JANUARY OF 2022, Janis Hughes was told she had two years to live. After two prior bouts of cancer, she was now told she had stage 4 breast cancer, which had already spread to her sternum, ribs, and right lung. The news devastated her, making her feel “a great weight” pressing on her chest, … Read more
Regulations the province insists are meant to put Alberta at the forefront of psychedelic therapy are actually restricting access to such treatment, say some clinic operators. Last October, the Alberta government unveiled first-in-Canada regulations governing the growing field that uses substances such as ketamine and psilocybin, the active ingredient in magic mushrooms to treat conditions … Read more
